What is the investment amount of Nantong Merck Phase II?

The total investment is 65.438+0.7 billion euros (about 65.438+0.27 billion RMB). The second phase of the project is Nantong pharmaceutical base. We will focus on producing Merck's related products in the fields of diabetes, thyroid dysfunction, cardiovascular diseases and other chronic diseases, including Gehuazhi, Youjialuo, Saizhi and Kang Xin. Merck predicted that in 20021year, the production capacity of Nantong pharmaceutical base will reach10 billion tablets/year, and the first batch of drugs produced by the base will be listed in the second half of 20 17.